<DOC>
	<DOCNO>NCT00357149</DOCNO>
	<brief_summary>To evaluate rate clinical complete response 6-8 week treatment docetaxel plus cisplatin 5-fluorouracil follow chemoradiotherapy chemoradiotherapy alone patient locally advance squamous cell carcinoma head neck .</brief_summary>
	<brief_title>Neoadjuvant Docetaxel Plus Cisplatin 5-fluorouracil ( TPF ) Followed Concomitant Chemoradiotherapy Chemoradiotherapy Alone Locally Advanced Squamous Cell Carcinoma Head Neck Patients ( SCCHNS )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Inclusion criterion : Histologically cytologically proven squamous cell carcinoma head neck . Primary tumor site eligible : oral cavity , oropharynx , hypopharynx . Although admittedly squamous cell type , follow tumor exclude theY responsiveness chemotherapy : tumor nasal paranasal cavity , larynx nasopharynx . Stage III IV disease without evidence distant metastasis verify chest X Ray and/or lung CT scan , abdominal ultrasound , CT ( liver function test abnormality ) ; bone scan case local symptom . At least one measurable lesion . Tumor consider inoperable evaluation multidisciplinary team ( i.e . surgeon , medical oncologist radiation oncologist ) . No previous chemotherapy radiotherapy reason previous surgery squamous cell carcinoma head neck patient ( biopsy ) allow time study entry . Karnofsky performance status ≥ 70 . No active alcohol addiction . Adequate bone marrow , hepatic renal function Patients must available treatment followup . Exclusion criterion Pregnant lactate woman woman childbearing potential use adequate contraception . Previous current malignancy site , exception adequately treat situ carcinoma cervix uterus , basal squamous cell carcinoma skin , cancer curatively treat surgery evidence disease least 5 year . Symptomatic peripheral neuropathy ≥ grade 2 Symptomatic alter hear ≥ grade 2 Other serious illness medical condition include : ) Unstable cardiac disease despite treatment , myocardial infarction within 6 month prior study entry.b ) History significant neurologic psychiatric disorder include dementia seizures.c ) Active uncontrolled infection.d ) Active peptic ulcer.e ) Hypercalcemia.f ) Chronic obstructive pulmonary disease require hospitalization year precede study entry History hypersensitivity reaction polysorbate 80 Patients require intravenous alimentation . Patients experience weight loss 20 % body weight 3 month precede study entry . Concomitant treatment anticancer therapy . Participation therapeutic clinical trial within 30 day study entry The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>